Phase I Clinical Trial of SYL040012, a Small Interfering RNA Targeting β-Adrenergic Receptor 2, for Lowering Intraocular Pressure

Autor: Moreno-Montañés, Javier, Sádaba, Belén, Ruz, Verónica, Gómez-Guiu, Almudena, Zarranz, Javier, González, María Victoria, Pañeda, Covadonga, Jimenez, Ana Isabel
Zdroj: In Molecular Therapy January 2014 22(1):226-232
Databáze: ScienceDirect